240 related articles for article (PubMed ID: 8649668)
1. Management of severe bronchiolitis: indications for ventilator support.
Gavin R; Anderson B; Percival T
N Z Med J; 1996 Apr; 109(1020):137-9. PubMed ID: 8649668
[TBL] [Abstract][Full Text] [Related]
2. [Perinatal history and hospitalization for bronchiolitis. A comparison with the impact-RSV Study Group].
Bonillo Perales A ; DíezDelgado Rubio J ; Ortega Montes A ; Infante Márquez P ; Jiménez Liria M ; Batlles Garrido J ; López Muñoz J
An Esp Pediatr; 2000 Dec; 53(6):527-32. PubMed ID: 11148149
[TBL] [Abstract][Full Text] [Related]
3. [Effects of nasal continuous positive airway pressure ventilation in infants with severe acute bronchiolitis].
Larrar S; Essouri S; Durand P; Chevret L; Haas V; Chabernaud JL; Leyronnas D; Devictor D
Arch Pediatr; 2006 Nov; 13(11):1397-403. PubMed ID: 16959476
[TBL] [Abstract][Full Text] [Related]
4. The severity of respiratory syncytial virus bronchiolitis in young infants in the United Arab Emirates.
Howidi M; Rajah J; Abushrar Z; Parsons H
J Trop Pediatr; 2007 Feb; 53(1):22-6. PubMed ID: 17008442
[TBL] [Abstract][Full Text] [Related]
5. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
Simoes EA; Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
[TBL] [Abstract][Full Text] [Related]
6. Respiratory development of 5- to 6- year-old children experiencing a first bronchiolitis episode before age one.
Sznajder M; Stheneur C; Albonico V; Dib S; Cau D; Chevallier B;
Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):392-6. PubMed ID: 16528903
[TBL] [Abstract][Full Text] [Related]
7. Helmet-delivered continuous positive airway pressure with heliox in respiratory syncytial virus bronchiolitis.
Mayordomo-Colunga J; Medina A; Rey C; Concha A; Los Arcos M; Menéndez S
Acta Paediatr; 2010 Feb; 99(2):308-11. PubMed ID: 19811455
[TBL] [Abstract][Full Text] [Related]
8. Is it safer to intubate premature infants in the delivery room?
Aly H; Massaro AN; Patel K; El-Mohandes AA
Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230
[TBL] [Abstract][Full Text] [Related]
9. Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up.
Valkonen H; Waris M; Ruohola A; Ruuskanen O; Heikkinen T
Allergy; 2009 Sep; 64(9):1359-65. PubMed ID: 19416146
[TBL] [Abstract][Full Text] [Related]
10. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.
Bradley JP; Bacharier LB; Bonfiglio J; Schechtman KB; Strunk R; Storch G; Castro M
Pediatrics; 2005 Jan; 115(1):e7-14. PubMed ID: 15629968
[TBL] [Abstract][Full Text] [Related]
11. Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants.
Broughton S; Bhat R; Roberts A; Zuckerman M; Rafferty G; Greenough A
Arch Dis Child; 2006 Jan; 91(1):26-30. PubMed ID: 16188957
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus infection and immunoprophylaxis for selected high-risk children in Central Australia.
Bolisetty S; Wheaton G; Chang AB
Aust J Rural Health; 2005 Oct; 13(5):265-70. PubMed ID: 16171499
[TBL] [Abstract][Full Text] [Related]
13. U-EPX levels and wheezing in infants and young children with and without RSV bronchiolitis.
Kristjánsson S; Wennergren D; Eriksson B; Thórarinsdóttir H; Wennergren G
Respir Med; 2006 May; 100(5):878-83. PubMed ID: 16198099
[TBL] [Abstract][Full Text] [Related]
14. The need for inotropic support in a subgroup of infants with severe life-threatening respiratory syncytial viral infection.
Kim KK; Frankel LR
J Investig Med; 1997 Oct; 45(8):469-73. PubMed ID: 9394100
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus infections in children admitted to the intensive care unit.
Van Steensel-Moll HA; Van der Voort E; Bos AP; Rothbarth PH; Neijens HJ
Pediatrie; 1989; 44(7):583-8. PubMed ID: 2812976
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants.
Broughton S; Roberts A; Fox G; Pollina E; Zuckerman M; Chaudhry S; Greenough A
Thorax; 2005 Dec; 60(12):1039-44. PubMed ID: 16227330
[TBL] [Abstract][Full Text] [Related]
17. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.
Sigurs N; Bjarnason R; Sigurbergsson F; Kjellman B; Björkstén B
Pediatrics; 1995 Apr; 95(4):500-5. PubMed ID: 7700748
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis.
Stevens TP; Sinkin RA; Hall CB; Maniscalco WM; McConnochie KM
Arch Pediatr Adolesc Med; 2000 Jan; 154(1):55-61. PubMed ID: 10632251
[TBL] [Abstract][Full Text] [Related]
19. Lung function in prematurely born infants after viral lower respiratory tract infections.
Broughton S; Sylvester KP; Fox G; Zuckerman M; Smith M; Milner AD; Rafferty GF; Greenough A
Pediatr Infect Dis J; 2007 Nov; 26(11):1019-24. PubMed ID: 17984809
[TBL] [Abstract][Full Text] [Related]
20. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
